Amarna Therapeutics appointed new CEO
Dutch Amarna Therapeutics has appointed Dr Steen Klysner. The new CEO has been active in the biotech industry for more than 30 years
ADVERTISEMENT
Log in here to read the desired article.
ADVERTISEMENT
This author has not written his bio yet.
But we are proud to say that Michael Kuhrt contributed 541 entries already.
Dutch Amarna Therapeutics has appointed Dr Steen Klysner. The new CEO has been active in the biotech industry for more than 30 years
In October Juan Carlos Jaramillo will take over the business from Wolfgang Bender as new Chief Medical Officer and member of the Valneva Management Board.
Andrew Topen is the new Chairman of the European Association for Bioindustries EuropaBio.
Swedish diagnostic company Immunovia AB announces Patrik Dahlen as new CEO starting November 2020.
Abigail Herron from Aviva Investors describes why AMR is a blind spot for investors and which action is needed to change it.
Barbara McManus as the new managing director of Nottingham-based Contract Research Organisation (CRO) HistologiX.
SPCs offer up to five and a half years of additional protection after patent expiration for pharmaceuticals in order to compensate the patent holder’s inability to exploit their inventions while products undergo lengthy regulatory approvals.
Prior to Danish Genmab A/S’s recent licence option deal with AbbVie Inc, Rentschler Biopharma has extended its collaboration with Genmab. European Biotechnology spoke with Rentschler Biopharma SE’s SVP Global BD Federico Pollano about the CDMO’s expertise in DuoBody® molecules production and the expansion of the CDMO’s U.S. production site in Milford.
If reopening the economy after the prolonged shutdown was the end of the beginning, then the successful development of vaccines and therapeutic antibodies has the potential to be the beginning of the end.
Richard Sachse started at the beginning of July as new Chief Medical Officer at Sotio a.s.

